Premium
Molecular and serologic analysis in the transmission of the GB hepatitis agents
Author(s) -
Schlauder George G.,
Dawson George J.,
Simons John N.,
PilotMatias Tami J.,
Gutierrez Robin A.,
Heynen Cynthia A.,
Knigge Mark F.,
Kurpiewski Gretchen S.,
Buijk Sheri L.,
Leary Thomas P.,
Muerhoff A. Scott,
Desai Suresh M.,
Mushahwar Isa K.
Publication year - 1995
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1890460117
Subject(s) - virology , biology , virus , antibody , epitope , serology , flavivirus , gb virus c , hepatitis c virus , flaviviridae , immunology
Two flavivirus‐like genomes have recently been cloned fron infectious tamarin ( Saguinus labiatus ) serum, derived from the human viral hepatitis GB strain, which is known to induce hepatitits in tamarins. In order to study the natural history of GB infections, further transmission studies were carried out in tamarins. Reverse‐transcription‐polymerase chain reaction and enzymelinked immunosorbant assays were developedfor the detection of RNA and antibodies associated with the two agents, GB virus‐A and GB virus‐B. The infectivity of both of these agents was demonstrated in tamarins to be filterable through a 0.1 μm filter. Tow distinct genomes were identified in the serum of eight of the infected tamarins, while in four tamarins, the genomes were detected independently of each other. Although specific antibodies to the GB virus‐B epitopes were detected in the serum of animals inoculated with both agents or GB virus‐B alone, antibodies to putative epitopes specific to GB virus‐A were not detected in any of the animals. All tamarins inoculated with serum containing GB virus‐B exhibited an elevation in liver enzyme levels after inoculation. Elevations of serum liver enzyme levels did not occur when GB virus‐A was the only agent detected in the serum. Infection with the original infectious tamarin inoculum conferred protection from reinfection with GB virus‐B but not with GB virus‐A. © 1995 Wiley‐Liss, Inc.